NovImmune
Latest round
- Series B
Last raised
- Feb 2014
Total raised
- $188M
Investors
- 10
About NovImmune
Founded in 1998 and headquartered in Geneva, Switzerland, NovImmune SA specializes in the research and development of monoclonal antibodies.NovImmune SA specializes in innovative biotechnology solutions, particularly in monoclonal antibody development aimed at treating autoimmune diseases and immune-mediated conditions.The revenue model for NovImmune SA is primarily based on partnership agreements and direct sales of its therapeutic products, structured around annual or multi-year contracts. This allows for a steady income stream as clients utilize their comprehensive suite of therapeutic solutions. The company is focusing on launching new therapeutic products aimed at expanding its market reach in Europe and North America by 2025. Additionally, NovImmune aims to strengthen its presence in Asia through strategic partnerships with local healthcare providers.
Who invested in NovImmune
10 investors across 5 rounds
See all investors in NovImmune
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NovImmune
Who invested in NovImmune?
NovImmune has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NovImmune raised?
NovImmune has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did NovImmune last raise money?
NovImmune's most recent round on record is a Series B, in Feb 2014.
What does NovImmune do?
Founded in 1998 and headquartered in Geneva, Switzerland, NovImmune SA specializes in the research and development of monoclonal antibodies.
Where is NovImmune headquartered?
NovImmune is headquartered in Geneva, Switzerland.
Which VCs invest in companies like NovImmune?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at NovImmune's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like NovImmune? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.